These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 24182544)
1. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia: a Cochrane review summary. Roberts H; Hickey M; Lethaby A Maturitas; 2014 Jan; 77(1):4-6. PubMed ID: 24182544 [No Abstract] [Full Text] [Related]
2. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Furness S; Roberts H; Marjoribanks J; Lethaby A; Hickey M; Farquhar C Cochrane Database Syst Rev; 2009 Apr; (2):CD000402. PubMed ID: 19370558 [TBL] [Abstract][Full Text] [Related]
3. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Furness S; Roberts H; Marjoribanks J; Lethaby A Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD000402. PubMed ID: 22895916 [TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy: estrogen after menopause. Gibaldi M Pharmacotherapy; 1996; 16(3):366-75. PubMed ID: 8726594 [No Abstract] [Full Text] [Related]
5. Postmenopausal hormone therapy and breast cancer. Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723 [TBL] [Abstract][Full Text] [Related]
6. [Hormone therapy and risk for venous thromboembolism in postmenopausal women]. Lacut K; Oger E Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617 [TBL] [Abstract][Full Text] [Related]
15. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136 [TBL] [Abstract][Full Text] [Related]
16. [Prevention of endometrial carcinoma in postmenopause]. Escudero Fernández M Rev Med Univ Navarra; 1993; 38(3):9-12. PubMed ID: 8134756 [No Abstract] [Full Text] [Related]
17. Clinical use of progestins in the menopausal patient: dosage and duration. Gambrell RD J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446 [TBL] [Abstract][Full Text] [Related]
18. Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen. de Lignieres B J Reprod Med; 1999 Feb; 44(2 Suppl):191-6. PubMed ID: 11392031 [TBL] [Abstract][Full Text] [Related]
19. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens. Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317 [TBL] [Abstract][Full Text] [Related]
20. Endometrial morphology and bleeding patterns as a function of progestogen supplementation. Sturdee DW Int J Fertil Menopausal Stud; 1996; 41(1):22-8. PubMed ID: 8673153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]